• All
  • Executive Search
  • Finance
  • M&A
  • Views

The acquisition of the FIBRINET system adds new novel technology to Royal Biologics' growing portfolio of Autologous Live Cell solutions HACKENSACK, N.J., September 1, 2020 (Newswire.com) - HACKENSACK, N.J., September 1, 2020...

SAN DIEGO, Aug. 31, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today...

Salt Lake City, UT – August 25, 2020 – DiscGenics, Inc., a clinical stage biopharmaceutical company developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative...

Q1 Revenue of $6.5 Billion Decreased 13% Reported and Approximately 17% Organic Q1 GAAP Diluted EPS of $0.36; Q1 Non-GAAP Diluted EPS of $0.62 DUBLIN, Aug. 25, 2020 (GLOBE NEWSWIRE)...